Director/PDMR Shareholding

RNS Number : 7310P

MyHealthChecked PLC

19 February 2021

 

MyHealthChecked Plc

("MyHealthChecked" or the "Company") 

Directors/PDMR Dealing

MyHealthChecked plc (AIM: MHC), the consumer home-testing healthcare company, announces that following Admission of the Placing Shares, the Firm Subscription Shares and Conversion Shares to trading this morning, the Participating Directors have acquired interests in new ordinary shares of 0.1p ("Ordinary Shares") as set out below, at a subscription price of 1.75p per Ordinary Share.

Name	Number of Subscription Shares	Number of Ordinary Shares held post admission of the  Placing Shares, the Firm Subscription Shares and the Conversion Shares	% of Ordinary Share Capital held post admission of the Placing Shares, the Firm Subscription Shares and the Conversion Shares
Penny McCormick	400,000	1,650,000	0.24%
Maddy Kennedy	400,000	1,650,000	0.24%
Lyn Rees	428,571	1,991,071	0.29%
Adam Reynolds	1,428,571	9,513,293	1.37%

All terms used above are as defined in the RNS of 29 January 2021.

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Penny McCormick
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	MYHEALTHCHECKED plc
b)	LEI	213800RBHY6LZDG13168
CO4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares
	Identification code	ISIN: GB00BYZ2R301
b)	Nature of the transaction	Subscription for cash
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			£0.0175	400,000
d)	Aggregated information
	- Aggregated volume	As above
	- Price
e)	Date of the transaction	19 February 2021
f)	Place of the transaction	London Stock Exchange, AIM

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Maddy Kennedy
2	Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification/Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	MYHEALTHCHECKED plc
b)	LEI	213800RBHY6LZDG13168
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares
	Identification code	ISIN: GB00BYZ2R301
b)	Nature of the transaction	Subscription for cash
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			£0.0175	400,000
d)	Aggregated information
	- Aggregated volume	As above
	- Price
e)	Date of the transaction	19 February 2021
f)	Place of the transaction	London Stock Exchange, AIM

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Lyn Rees
2	Reason for the notification
a)	Position/status	Non-Executive Director
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	MYHEALTHCHECKED plc
b)	LEI	213800RBHY6LZDG13168
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares
	Identification code	ISIN: GB00BYZ2R301
b)	Nature of the transaction	Subscription for cash
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			£0.0175	428,571
d)	Aggregated information
	- Aggregated volume	As above
	- Price
e)	Date of the transaction	19 February 2021
f)	Place of the transaction	London Stock Exchange, AIM

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Adam Reynolds
2	Reason for the notification
a)	Position/status	Non-Executive Chairman
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	MYHEALTHCHECKED plc
b)	LEI	213800RBHY6LZDG13168
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares
	Identification code	ISIN: GB00BYZ2R301
b)	Nature of the transaction	Subscription for cash
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			£0.0175	1,428,571
d)	Aggregated information
	- Aggregated volume	As above
	- Price
e)	Date of the transaction	19 February 2021
f)	Place of the transaction	London Stock Exchange, AIM

For further information please visit http://www.myhealthcheckedplc.com/ or contact:

MyHealthChecked plc	www.myhealthcheckedp lc .com
P enny McCormick , Chief Executive Officer	via Walbrook PR
Maddy Kennedy, Chief Financial Officer
SPARK Advisory Partners Limited (NOMAD)	Tel: [phone]
Neil Baldwin
Oberon Investments (Broker)	Tel: [phone]
Mike Seabrook	[e-mail]
Walbrook PR Ltd (Media & Investor Relations)	Tel: [phone] or  [e-mail]
Paul McManus	Mob: [phone]

About MyHealthChecked PLC   (   www.myhealthcheckedplc.com   )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company with two diverse, customer-facing at-home testing brands in its portfolio:

MyHealthChecked  is the umbrella brand of a range of at-home DNA and RNA tests, now in development following the recent acquisition of The Genome Store. The tests will be made available on line, and would be viable for over the counter purchase.

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

Mylo  targets the personalized mobile health market, with a primary focus on hormone testing and increasing a woman's chances of naturally getting pregnant, and providing insight to unexplained infertility. The myLotus range of IVDs are CE-marked and are expected to be beneficial to users who have been unable to conceive after 6 months of trying. This highly motivated target group of women won't typically be offered medical intervention until after 12 months of unsuccessfully trying to conceive, with IVF not usually offered until after two years of trying to conceive. Research indicates couples start to take positive action ahead of this time typically with little medical support to help them do so.

The myLotus range of IVDs are currently the UK's only consumer product which allows both quantitative and qualitative home (self-test) test measurement of a woman's personal luteinizing hormone (LH) during ovulation and human chorionic gonadotropin ("hCG") hormone level during pregnancy.

 

END

 

 

DSHKKLBFFLLEBBB